Tenderwize
Back to tender search

Framework contracts for innovative infectious disease therapeutics

Health and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency·Brussels, Belgium·EUR 252M·Expired · Sep 02, 2026·Neg W Call·Services·Framework
High valueStructured notice only
Original notice title

Belgium – Research and development services and related consultancy services – Multiple sourcing Framework Contracts to speed up the development of and access to innovative medical countermeasures Next Generation Therapeutics for Infectious Diseases

72/100

Opportunity Score

Needs reviewHigh complexity
ServicesFrameworkExpired
Why this score?

Opportunity

72 / 100

Complexity

88 / 100

Risk factors

The procurement documents appear available through the Funding and Tenders Portal, but their extracted content was not...

The full exclusion grounds and any selection requirements are deferred to procurement documents and are not specified i...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Tender facts

Contracting authority
Health and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency
Country
Belgium
CPV
73000000 - Research and development services and related consultancy services +1 more
Deadline
Sep 02, 2026
Estimated value
EUR 252M

Overview

Moderate opportunity

Key Facts

  • EUR 252M estimated value
  • Framework procurement
  • Services contract
  • 2 lots
  • Development of innovative next-generation therapeutics for infectious diseases under competitive development phases within a Pre-Commercial Procurement model.
  • Potential treatment areas include viral infections, infection-related acute respiratory distress syndrome, and sepsis.
Show full summary

HaDEA is procuring two EU-funded framework service lots under a competitive phased Pre-Commercial Procurement procedure for innovative next-generation therapeutics for infectious diseases. The scope includes pathogen-targeted and host-targeted therapeutics, combination therapies, alternative administration routes, and therapies addressing viral infections, infection-related ARDS or sepsis. The total estimated value is EUR 252,000,000. Electronic submission through the Funding and Tenders Portal is required by 2 September 2026 at 14:00:59 UTC. The opportunity is substantial but requires detailed review of procurement documents that were not provided or analyzed.

Risks

The procurement documents appear available through the Funding and Tenders Portal, but their extracted content was not...

The full exclusion grounds and any selection requirements are deferred to procurement documents and are not specified i...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • The procurement uses a competitive development in phases under Pre-Commercial Procurement and is structured as framework contracts.

Administrative

  • Two lots are available and the notice states that a tenderer may submit for and be awarded a maximum of two lots.
  • Electronic submission is required through the Funding and Tenders Portal submission endpoint.

Requirements may be incomplete.

Award Criteria

Lot 1

Quality criterion weighted at 80%; detailed assessment method is in the procurement documents. — 80%Price criterion weighted at 20%; detailed assessment method is in the procurement documents. — 20%

Lot 2

Quality criterion weighted at 80%; detailed assessment method is in the procurement documents. — 80%Price criterion weighted at 20%; detailed assessment method is in the procurement documents. — 20%

Buyer

Lots (2)

LOT-0001

Highly Innovative Therapeutics

Framework service lot for pathogen-targeted scalable therapeutics, innovative combination therapies, and therapeutics designed for administration through routes other than intravenous administration.

ServicesFrameworkEU fundedElectronic submission

EUR 252M

Estimated value

Duration

108 MONTH

Category

Research

Award Criteria

Best price-quality ratio

Deadline

Expired Sep 02, 2026

LOT-0002

Advanced Therapeutics

Framework service lot for host-targeted scalable therapeutics, innovative combination therapies, and therapeutics designed for administration through routes other than intravenous administration.

ServicesFrameworkEU fundedElectronic submission

EUR 252M

Estimated value

Duration

69 MONTH

Category

Research

Award Criteria

Best price-quality ratio

Deadline

Expired Sep 02, 2026

Procurement Details

Publication date
01 Jul 2026
Languages
English, Bulgarian

Reference metadata

Legal basis
32024R2509

Reference IDs

Tender ID
456593-2026

Documents (2)

Similar tenders

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy